Availability of Transgene’s 2024 Universal Registration Document (URD)
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers – AMF) on April 10, 2025, under number D.25-0243.
/EIN News/ -- This document, available on the AMF’s website (www.amf-france.org), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene’s website (www.transgene.fr)
It includes the following documents:
- the Annual Financial Report;
- the Board of Directors’ Corporate Governance Report;
- the Statutory Auditors’ Reports;
- information on the Company’s share capital, including the share buyback program;
- information on the Statutory Auditors’ fees.
The Universal Registration Document also includes information on the Company’s Environmental, Social and Governance (ESG) factors.
Attachment
Distribution channels: Business & Economy ...
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release